-
Technologies
Divisions

Publications

Selected publications from Dr Vanessa Bryant

Chan S, Margetts M, Wang L, Godsell J, Chatelier J, Liu B, Slade C, Brett A, Singh K, Bryant V, Howson L. Characterizing the Molecular and Functional Consequences of Dominant-Negative IFNGR1 Mutations in Mendelian Susceptibility to Mycobacterial Disease. Journal of Allergy and Clinical Immunology. 2025;155(2):10.1016/j.jaci.2024.12.1040

Rubin AF, Stone J, Bianchi AH, Capodanno BJ, Da EY, Dias M, Esposito D, Frazer J, Fu Y, Grindstaff SB, Harrington MR, Li I, McEwen AE, Min JK, Moore N, Moscatelli OG, Ong J, Polunina PV, Rollins JE, Rollins NJ, Snyder AE, Tam A, Wakefield MJ, Starita LM, Bryant VL, Marks DS, Fowler DM. MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assays. Genome Biology. 2025;26(1):10.1186/s13059-025-03476-y

Adhikari A, Maddumage J, Eriksson EM, Annesley SJ, Lawson VA, Bryant VL, Gras S. Beyond acute infection: mechanisms underlying post‐acute sequelae of COVID‐19 (PASC). The Medical Journal of Australia. 2024;221(S9):10.5694/mja2.52456

Atkin-Smith GK, Santavanond JP, Light A, Rimes JS, Samson AL, Er J, Liu J, Johnson DN, Le Page M, Rajasekhar P, Yip RKH, Geoghegan ND, Rogers KL, Chang C, Bryant VL, Margetts M, Keightley MC, Kilpatrick TJ, Binder MD, Tran S, Lee EF, Fairlie WD, Ozkocak DC, Wei AH, Hawkins ED, Poon IKH. In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions. Nature Communications. 2024;15(1):10.1038/s41467-024-52867-5

Chan S, Morgan B, Yong MK, Margetts M, Farchione AJ, Lucas EC, Godsell J, Giang NA, Slade CA, von Borstel A, Bryant VL, Howson LJ. Cytomegalovirus drives Vδ1+ γδ T cell expansion and clonality in common variable immunodeficiency. Nature Communications. 2024;15(1):10.1038/s41467-024-48527-3

Zhou JJ, Jin C, Leang ZX, Chatelier J, Godsell J, Tsang S, Douglass JA, Yong MK, Slavin M, Bryant VL, Slade CA, Chan S. A single-center experience of COVID-19 infection in patients with primary immunodeficiency. Journal of Allergy and Clinical Immunology Global. 2024;3(2):10.1016/j.jacig.2024.100241

Cocks B, Gail E, Green S, Bryant V, Slade C, Tang M, Cole T, Douglass J. 55 Diagnostic utility of the whole blood transcriptome and mucosal microbiome alterations in patients with primary immunodeficiency. Clinical Immunology. 2024;262:10.1016/j.clim.2024.109997

Brown DV, Anttila CJA, Ling L, Grave P, Baldwin TM, Munnings R, Farchione AJ, Bryant VL, Dunstone A, Biben C, Taoudi S, Weber TS, Naik SH, Hadla A, Barker HE, Vandenberg CJ, Dall G, Scott CL, Moore Z, Whittle JR, Freytag S, Best SA, Papenfuss AT, Olechnowicz SWZ, MacRaild SE, Wilcox S, Hickey PF, Amann-Zalcenstein D, Bowden R. A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq. Genomics. 2024;116(2):10.1016/j.ygeno.2024.110793

Moscatelli OG, Russell AK, Henneken LM, Hardy MY, Mazarakis N, Higgins R, Ekin J, McLeod H, Simkin P, Licciardi PV, Bryant VL, Tye-Din JA. Impaired IgM Memory B Cell Function Is Common in Coeliac Disease but Conjugate Pneumococcal Vaccination Induces Robust Protective Immunity. Vaccines. 2024;12(2):10.3390/vaccines12020214

Farchione AJ, Cheon H, Hodgkin PD, Bryant VL. Quantifying Human Naïve B Cell Proliferation Kinetics and Differentiation in Controlled In Vitro Cell Culture. Methods in Molecular Biology. 2024;2826:10.1007/978-1-0716-3950-4_13

Interested in supporting our research?

Your support will help WEHI’s researchers make discoveries and find treatments to ensure healthier, longer lives for you and your loved ones.

Contact our friendly team to find out how you can help.